Adoption of Stereotactic Body Radiotherapy for Stage IA Non–Small Cell Lung Cancer Across the United States

BACKGROUND: Stereotactic body radiotherapy (SBRT) is a treatment option for stage I non–small cell lung cancer (NSCLC), providing a potentially curative therapy for patients who are nonsurgical candidates. This study describes the adoption of SBRT vs other treatment options across the United States,...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmes, Jordan A., Zagar, Timothy M., Chen, Ronald C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649706/
https://www.ncbi.nlm.nih.gov/pubmed/31360829
http://dx.doi.org/10.1093/jncics/pkx003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649706/
https://www.ncbi.nlm.nih.gov/pubmed/31360829
http://dx.doi.org/10.1093/jncics/pkx003

Ejemplares similares